Cholinesterase inhibitors improve cognition and memory loss in AD patients by preventing ACh from being degraded by acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) [10,11]. The gene discussed is ACHE; the disease is Alzheimer disease.